# AirScan Inc. d/b/a HemaTechnologies – FDA Inspection, Mar 24, 2023

Source: https://www.keypedia.com/records/fda_inspections/airscan-inc-dba-hematechnologies/c4be87e9-cdf7-47cc-85a9-ba05eebbfe8c
Source feed: FDA_Inspections

> FDA inspection 1201529 of AirScan Inc. d/b/a HemaTechnologies, March 24, 2023. Classification: No Action Indicated (NAI). 9 citations under 21 CFR part 820. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1201529
- Company Name: AirScan Inc. d/b/a HemaTechnologies
- Inspection Date: 2023-03-24
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Postmarket Assurance: Devices
- Product Type: Devices
- Center: Medical Devices & Rad Health
- Office Name: Center for Devices and Radiological Health
- Citation Count: 9

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/colin-e-tack/5bdbf977-d4ac-48fe-81cc-ada89379ed0d)

Company: https://www.keypedia.com/companies/airscan-inc-dba-hematechnologies/9a63713a-2f50-47ba-a5c8-80aed7405435

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7
